Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Jan 7, 2022BD Kiestra™ IdentifA Receives 510(K) Clearance for Automated Sample Processing and MALDI Target PreparationBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)...
-
Jan 6, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that in the interest of the health and safety of its shareholders, directors, officers,...
Jan 6, 2022Highlights Company's Impact on Advancing Cybersecurity Maturity in Health CareBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released its second annual cybersecurity report to update stakeholders on the state of health...
-
Jan 5, 2022
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report financial results for its first quarter of fiscal year 2022 on Thursday, Feb. 3, 2022. A news release will be...
-
Dec 22, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will virtually present at the 40th Annual J.P. Morgan Healthcare Conference via...
Dec 22, 2021Tests now available online through Everly Health and in-store at Winn-Dixie, Harveys Supermarket, and Fresco y MásBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical company, today announced the BD Veritor™ At-Home COVID-19 Test is now available for purchase through Everly Health, a...
-
Dec 21, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Embecta Corp. ("embecta"), the independent, publicly-traded company that will hold...
Dec 21, 2021Advances company's innovation focus on enabling new care settings and accelerating smart connected careBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of privately held Scanwell Health Inc., a leader in...
Dec 17, 2021BD COR™ MX for Infectious Disease Testing Receives CE Mark and is Final Instrument Introduced on BD COR™ SystemBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has expanded the BD COR™ System to include a new MX instrument for high-throughput...
Dec 15, 2021€70 Million Investment to Establish New Research Laboratories, Jobs in Software Engineering, Informatics and CybersecurityLIMERICK, IRELAND (15TH Dec. 2021) –BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to create more than 130 new jobs and invest €
Dec 9, 2021Stamford, Conn. – Dec. 9, 2021 – The global medical technology company, BD (Becton, Dickinson and Company), has committed $500,000 to improve quality of care and reduce health inequities for...
Dec 9, 2021- Acquisition complements BD's core portfolio - adding an innovative, broadly applicable surgical sealant to a suite of BD biosurgery products already relied upon in the operating room.BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired Tissuemed, Ltd., a privately held firm headquartered in Leeds, England...
Dec 8, 2021Addition of 100 local jobs will play key role in bolstering manufacturing capacity to supply the market with pre-filled flush syringes for use in health care settingsDROGHEDA, IRELAND (December 8, 2021) – BD (Becton Dickinson and Company), a leading global medical technology company, held a ribbon cutting ceremony today to announce the creation of 100 new...
Dec 6, 2021BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that "embecta" [pronounced em-BECK-tah] will be the name of the independent,...
Dec 2, 2021- Acquisition marks BD's entry point to the treatment of Chronic Venous Insufficiency -- adding transformative solutions to its existing venous disease portfolio with the potential to reshape patient care.BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired Venclose, Inc., a provider of solutions for the treatment of chronic...
Dec 1, 2021Progress Builds Strong Foundation for Bold 2030+ ESG Goals to Advance the World of Health for AllBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the release of its 2021 Global Inclusion, Diversity and Equity (ID&E) Report. The...
-
Nov 30, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding testing for the COVID-19 Omicron variant of concern....
Nov 29, 2021Digital Health Pioneer to Focus on External Innovation; Becomes Co-Chair of BD Scientific Advisory BoardBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Joseph M. Smith has been named senior vice president and chief scientific...
Nov 24, 2021BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Francesca DeMartino has been named senior vice president of investor relations for the...
-
Nov 16, 2021New facility will expand BD’s capacity to supply the European market with pre-fillable syringes for use in applications such as vaccines and other biologic drugs; add 150 local jobs by 2024.
FRANKLIN LAKES, N.J. (November 16, 2021) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, broke ground on a €165 million ($200 million USD)...
Nov 12, 2021- Innovation agenda focuses on advancing human health through smart connected care, new care settings and chronic disease outcomesBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will begin its Investor Day at 8 a.m. ET today to share how it plans to leverage the breadth and depth...
Nov 4, 2021- Fourth fiscal quarter revenues of $5.1 billion grew 7.3% on a reported basis or 5.9% on a currency-neutral basis.BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for the fourth fiscal quarter and full fiscal year ended September 30, 2021....
-
Nov 4, 2021
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.87 per common share, an increase of 4.8% from the previous quarter. The dividend...
Oct 28, 2021BARDA to Invest $24.7 Million for BD to Develop New Tests for Core Labs, Hospitals and Point-of-Care LocationsBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the formation of a strategic, public-private partnership with the Biomedical Advanced...
Oct 26, 2021Event will provide strategic update, with focus on company's innovation and growth agendasBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will host a virtual investor day on Friday, Nov. 12, 2021 at 8 a.m., which will...